150 related articles for article (PubMed ID: 30527747)
21. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium.
Khoo KH; Dell A; Morris HR; Brennan PJ; Chatterjee D
J Biol Chem; 1995 May; 270(21):12380-9. PubMed ID: 7759478
[TBL] [Abstract][Full Text] [Related]
22. How Mycobacterium tuberculosis subverts host immune responses.
Józefowski S; Sobota A; Kwiatkowska K
Bioessays; 2008 Oct; 30(10):943-54. PubMed ID: 18800365
[TBL] [Abstract][Full Text] [Related]
23. Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of mycobacteria.
Yonekawa A; Saijo S; Hoshino Y; Miyake Y; Ishikawa E; Suzukawa M; Inoue H; Tanaka M; Yoneyama M; Oh-Hora M; Akashi K; Yamasaki S
Immunity; 2014 Sep; 41(3):402-413. PubMed ID: 25176311
[TBL] [Abstract][Full Text] [Related]
24. Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells.
Tailleux L; Neyrolles O; Honoré-Bouakline S; Perret E; Sanchez F; Abastado JP; Lagrange PH; Gluckman JC; Rosenzwajg M; Herrmann JL
J Immunol; 2003 Feb; 170(4):1939-48. PubMed ID: 12574362
[TBL] [Abstract][Full Text] [Related]
25. Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses.
Chen W; Bao Y; Chen X; Burton J; Gong X; Gu D; Mi Y; Bao L
Med Microbiol Immunol; 2016 Apr; 205(2):119-31. PubMed ID: 26318856
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans.
Kaur D; Lowary TL; Vissa VD; Crick DC; Brennan PJ
Microbiology (Reading); 2002 Oct; 148(Pt 10):3049-3057. PubMed ID: 12368438
[TBL] [Abstract][Full Text] [Related]
27. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages.
Schlesinger LS; Kaufman TM; Iyer S; Hull SR; Marchiando LK
J Immunol; 1996 Nov; 157(10):4568-75. PubMed ID: 8906835
[TBL] [Abstract][Full Text] [Related]
28. Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact on in vitro inflammatory responses.
Afonso-Barroso A; Clark SO; Williams A; Rosa GT; Nóbrega C; Silva-Gomes S; Vale-Costa S; Ummels R; Stoker N; Movahedzadeh F; van der Ley P; Sloots A; Cot M; Appelmelk BJ; Puzo G; Nigou J; Geurtsen J; Appelberg R
Cell Microbiol; 2013 Apr; 15(4):660-74. PubMed ID: 23121245
[TBL] [Abstract][Full Text] [Related]
29. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties.
Guérardel Y; Maes E; Briken V; Chirat F; Leroy Y; Locht C; Strecker G; Kremer L
J Biol Chem; 2003 Sep; 278(38):36637-51. PubMed ID: 12829695
[TBL] [Abstract][Full Text] [Related]
30. Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages.
Yoshida A; Koide Y
Infect Immun; 1997 May; 65(5):1953-5. PubMed ID: 9125587
[TBL] [Abstract][Full Text] [Related]
31. The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction.
Appelmelk BJ; den Dunnen J; Driessen NN; Ummels R; Pak M; Nigou J; Larrouy-Maumus G; Gurcha SS; Movahedzadeh F; Geurtsen J; Brown EJ; Eysink Smeets MM; Besra GS; Willemsen PT; Lowary TL; van Kooyk Y; Maaskant JJ; Stoker NG; van der Ley P; Puzo G; Vandenbroucke-Grauls CM; Wieland CW; van der Poll T; Geijtenbeek TB; van der Sar AM; Bitter W
Cell Microbiol; 2008 Apr; 10(4):930-44. PubMed ID: 18070119
[TBL] [Abstract][Full Text] [Related]
32. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages.
Schlesinger LS; Hull SR; Kaufman TM
J Immunol; 1994 Apr; 152(8):4070-9. PubMed ID: 8144972
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterium tuberculosis protein Rv2220 induces maturation and activation of dendritic cells.
Choi S; Choi HG; Lee J; Shin KW; Kim HJ
Cell Immunol; 2018 Jun; 328():70-78. PubMed ID: 29625705
[TBL] [Abstract][Full Text] [Related]
34. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
35. Lipoarabinomannans activate the protein tyrosine kinase Hck in human neutrophils.
Astarie-Dequeker C; Nigou J; Puzo G; Maridonneau-Parini I
Infect Immun; 2000 Aug; 68(8):4827-30. PubMed ID: 10899899
[TBL] [Abstract][Full Text] [Related]
36. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages.
Ferguson JS; Voelker DR; McCormack FX; Schlesinger LS
J Immunol; 1999 Jul; 163(1):312-21. PubMed ID: 10384130
[TBL] [Abstract][Full Text] [Related]
37. A truncated lipoglycan from mycobacteria with altered immunological properties.
Birch HL; Alderwick LJ; Appelmelk BJ; Maaskant J; Bhatt A; Singh A; Nigou J; Eggeling L; Geurtsen J; Besra GS
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2634-9. PubMed ID: 20133807
[TBL] [Abstract][Full Text] [Related]
38. Structural Variability of Lipoarabinomannan Modulates Innate Immune Responses within Infected Alveolar Epithelial Cells.
Liu H; Gui X; Chen S; Fu W; Li X; Xiao T; Hou J; Jiang T
Cells; 2022 Jan; 11(3):. PubMed ID: 35159170
[No Abstract] [Full Text] [Related]
39. Dendritic cells and Mycobacterium tuberculosis: which is the Trojan horse?
Herrmann JL; Lagrange PH
Pathol Biol (Paris); 2005 Feb; 53(1):35-40. PubMed ID: 15620608
[TBL] [Abstract][Full Text] [Related]
40. Mycobacteria target DC-SIGN to suppress dendritic cell function.
Geijtenbeek TB; Van Vliet SJ; Koppel EA; Sanchez-Hernandez M; Vandenbroucke-Grauls CM; Appelmelk B; Van Kooyk Y
J Exp Med; 2003 Jan; 197(1):7-17. PubMed ID: 12515809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
